Overall Status

Recruiting (2)

Completed (1)

Phase

phase 2 (3)

Sponsor

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

Thomas Jefferson University (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

adenovirus 5/f35-human guanylyl cyclase c-padre (1)

bevacizumab (1)

biospecimen collection (1)

capecitabine (1)

ipilimumab (1)

nivolumab (1)

oxaliplatin (1)

Study Documents

Intervention Type

biological (3)

drug (1)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

small intestinal adenocarcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting

Acinar Cell Carcinoma
+93 more

Biospecimen Collection
+2 more

Birmingham, Alabama
+998 more

Aug 23, 2022

Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus

Recruiting

Pancreatic Ductal Adenocarcinoma
+37 more

Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE

Philadelphia, Pennsylvania

Sidney Kimmel Cancer Center at Thomas Jefferson University

Nov 2, 2021

Ampulla of Vater Adenocarcinoma, Small Intestinal Adenocarcinoma, Stage III Ampulla of Vater Cancer AJCC v8 Trial in Houston

Completed

Has Results

Ampulla of Vater Adenocarcinoma
+9 more

Bevacizumab
+2 more

Houston, Texas

M D Anderson Cancer Center

Sep 1, 2020